Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Sep 24 | ZBIO Zenas BioPharma | Common Stock | Buy | Acquire P | Yes | No | 17 | 441,176 | 7.50 mm | 1,110,237 |
16 Sep 24 | ZBIO Zenas BioPharma | Common Stock | Conversion | Acquire C | Yes | No | 0 | 669,061 | 0.00 | 669,061 |
16 Sep 24 | ZBIO Zenas BioPharma | Common Stock | Buy | Acquire P | Yes | No | 17 | 441,176 | 7.50 mm | 1,946,564 |
16 Sep 24 | ZBIO Zenas BioPharma | Common Stock | Conversion | Acquire C | Yes | No | 0 | 1,505,388 | 0.00 | 1,505,388 |
16 Sep 24 | ZBIO Zenas BioPharma | Series C Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 5,809,528 | 0.00 | 0 |
16 Sep 24 | ZBIO Zenas BioPharma | Series C Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 13,071,439 | 0.00 | 0 |
12 Sep 24 | ZBIO Zenas BioPharma | Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 37,000 | 629.00 k | 37,000 |
13 Jun 24 | TRVN Trevena | Stock Option Common Stock | Grant | Acquire A | No | No | 0.4 | 13,700 | 5.48 k | 13,700 |
20 May 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.01 | 60,000 | 120.60 k | 60,000 |
16 May 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.01 | 30,000 | 60.30 k | 30,000 |